However, a previous study revealed that diabetes increased caspase-3 in diabetic rat kidneys, while the dipyridamole treatment reduced the activities of caspase-3 in diabetic rat nephropathy [16]. The gene discussed is CASP3; the disease is diabetes mellitus.